πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9987326

Klotho protein and related compounds for the treatment and diagnosis of cancer

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9988447

Treatment of diabetes

XBIOTECH INC. Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9981968

Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disord

Northwestern University Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9977875

Systems and methods of managing treatment of a chronic condition by symptom tracking

Corcept Therapeutics Incorporated Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9975944

Synthetic peptides for the treatment of autoimmune diseases

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9974802

Composition of novel carbohydrate drug for treatment of human diseases

GALECTIN THERAPEUTICS, INC. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9968631

Method for treatment of pulmonary fibrosis

GALECTIN THERAPEUTICS, INC. Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9968642

Compositions and methods for treatment of pain

Northwestern University Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9968586

Mast cell stabilizers treatment for systemic disorders

Patara Pharma, LLC Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9962370

Methods of treatment associated with the granulocyte colony-stimulating factor receptor

Ligand Pharmaceuticals Incorporated Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9963715

Methods and compositions for treatment of a genetic condition

Sangamo Therapeutics, Inc. Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9962363

Mast cell stabilizers treatment for systemic disorders

Patara Pharma, LLC Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9957329

Factor XII inhibitors for the treatment of neurological inflammatory disorders

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9956282

Bacterial compositions and methods of use thereof for treatment of immune system disorders

Seres Therapeutics, Inc. Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950044

Treatment of pulmonary vascular remodeling with neprilysin

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949962

Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treat

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU β€œPHARMENTERPRISES” Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9944603

Compounds and methods for the treatment of cystic fibrosis

Flatley Discovery Lab, LLC Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9944918

Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9943594

Methods for the treatment of rheumatoid arthritis

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937141

Carcinoma diagnosis and treatment, based on ODC1 genotype

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937159

Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and an

Lutonix, Inc. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937217

Method of inhibiting ABCG2 and related treatments

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937228

Treatment of myocardial infarction by inhibiting the action of mAKAPΞ²

Anchored RSK3 Inhibitors, LLC Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938344

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colo

PRECISION BIOLOGICS, INC. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted